Product Description: erythrocyte binding antigen-181
SignalP Peptide: MKGKMNMCLFFFYSILYVVLCTYVLG
# Transmembrane Domains: 2
EC Numbers: None
Curated GO (PlasmoDB):
Type | GO Term | Name |
---|---|---|
Component | GO:1903561 | extracellular vesicle |
Component | GO:0020009 | microneme |
Function | GO:0008201 | heparin binding |
Function | GO:0033691 | sialic acid binding |
Process | GO:0098609 | cell-cell adhesion |
Process | GO:0044409 | entry into host |
Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):
Stage | LR class | MCA mean | MCA prop. zeros |
---|---|---|---|
Sporozoite | possibly expressed | N/A | N/A |
Ring | expressed | 0.68 | 0.80 |
Trophozoite | possibly expressed | 0.09 | 0.95 |
Schizont | expressed | 0.47 | 0.85 |
Gametocyte | possibly expressed | 0.05 | 0.97 |
More info:
Old (Pf3D7v3) Gene ID: PF3D7_0102500
Resistome Missense Mutations: None
Resistome Compounds with Missense Mutations: None
Resistome # Samples with Disruptive Mutations: 0 (0 missense, 0 "interesting" missense)
Zhang Phenotype: Mutable in CDS
MIS: 0.999 | MFS: -2.102 | #Insertions: 1
PlasmoGEM Phenotype: Essential (Pb ortholog: PBANKA_1332700)
RMgmDB ABS Phenotype: N/A
More info: PhenoPlasm Link
AlphaFill Uniprot ID: Q8I2B4
"Best" AlphaFill ligand hit: 3PO (triphosphate, Local RMSD=0.31) with 5MZA (Global RMSD=4.70)
No associated EC numbersNo evidence of orthology to BindingDB entries
MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:
Homozygous genotype calls only
variant type | common | rare | doubleton | singleton |
---|---|---|---|---|
synonymous | 6 | 54 | 16 | 83 |
disruptive | 69 | 195 | 90 | 222 |
missense | 54 | 150 | 78 | 176 |
Any inclusion in genotype call
variant type | common | rare | doubleton | singleton |
---|---|---|---|---|
synonymous | 18 | 85 | 48 | 77 |
disruptive | 110 | 379 | 146 | 301 |
missense | 79 | 281 | 124 | 219 |
PlasmoDB Total SNPs: 369
Non-coding: 248 | Synonymous: 55 | Nonsynonymous: 66 | Stop Codon: 0
Protein Length: 1567 | Molecular Weight (kDa): 181.15
UniProt ID(s): A0A0K2RVP3, A0A0K2RVP5, A0A0K2RVP8, A0A0K2RVS8, A0A0K2RWA2, A0A0K2RWA7, Q105Z6, Q105Z8, Q106B2, Q6RI89, Q6RKB5, Q6RKB6, Q6RKB8, Q6RKC0, Q6RKC1, Q6RKC2, Q6RKC3, Q6RKC4, Q8I2B4, Q8IAD5, Q8IAD6
PDB ID(s): None
Isoelectric Point: 4.71
Protein Domain Annotations:
Source | Family ID | Description |
---|---|---|
InterPro | IPR008602 | Duffy-antigen binding |
InterPro | IPR021620 | Erythrocyte binding antigen 175, C-terminal |
PFam | PF05424 | Duffy-antigen binding |
PFam | PF11556 | Erythrocyte binding antigen 175, C-terminal |
Superfamily | SSF140924 | N/A |
PMID | Title | Authors | DOI/Link |
---|---|---|---|
12368867 | Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. | Hall N, Pain A, ..., Barrell BG | 10.1038/nature01095 |
12556470 | A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparumdefines a new trypsin-resistant receptor on human erythrocytes. | Gilberger TW, Thompson JK, ..., Cowman AF | 10.1074/jbc.M211446200 |
15477199 | Myosin-like sequences in the malaria parasite Plasmodium falciparum bind humanerythrocyte membrane protein 4.1. | Lanzillotti R, Coetzer TL | https://pubmed.ncbi.nlm.nih.gov/15477199/ |
24212193 | Analyses of interactions between heparin and the apical surface proteins ofPlasmodium falciparum. | Kobayashi K, Takano R, ..., Kato K | 10.1038/srep03178 |
28944300 | Proteomic analysis of extracellular vesicles from a Plasmodium falciparum Kenyanclinical isolate defines a core parasite secretome. | Abdi A, Yu L, ..., Rayner J | 10.12688/wellcomeopenres.11910.2 |
25288451 | Intrinsic disorder within the erythrocyte binding-like proteins from Plasmodium falciparum | Blanc M, Coetzer TL, ..., Jensen MR | 10.1016/j.bbapap.2014.09.023 |
23118907 | Plasmodium falciparum field isolates from South America use an atypical red blood cell invasion pathway associated with invasion ligand polymorphisms | Lopez-Perez M, Villasis E, ..., Lustigman S | 10.1371/journal.pone.0047913 |
27427762 | Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy | Goh YS, Peng K, ..., Renia L | 10.1371/journal.pone.0159347 |
28787025 | Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion | Tijani MK, Babalola OA, ..., Persson KEM | 10.1371/journal.pone.0182187 |
37653544 | Recent increase in low complexity polygenomic infections and sialicacid-independent invasion pathways in Plasmodium falciparum from Western Gambia | Nganyewo NN, Bojang F, ..., Amambua-Ngwa A | 10.1186/s13071-023-05929-4 |
21160096 | [Proteins involved in invasion of human red blood cells by malaria parasites] | Jaskiewicz E, Graczyk J, Rydzak J | https://pubmed.ncbi.nlm.nih.gov/21160096/ |
20843207 | Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-densityparasitemia | Richards JS, Stanisic DI, ..., Beeson JG | 10.1086/656413 |
20050806 | Erythrocyte invasion and merozoite ligand gene expression in severe and mildPlasmodium falciparum malaria | Gomez-Escobar N, Amambua-Ngwa A, ..., Conway DJ | 10.1086/649902 |
17984363 | Differential antibody responses to Plasmodium falciparum invasion ligand proteinsin individuals living in malaria-endemic areas in Brazil and Cameroon | Ford L, Lobo CA, ..., Lustigman S | https://pubmed.ncbi.nlm.nih.gov/17984363/ |
23110555 | Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru | Villasis E, Lopez-Perez M, ..., Lustigman S | 10.1186/1475-2875-11-361 |
19421327 | Case-control approach to identify Plasmodium falciparum polymorphisms associated with severe malaria | Chokejindachai W, Conway DJ | 10.1371/journal.pone.0005454 |
25870227 | Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity | Bowyer PW, Stewart LB, ..., Conway DJ | 10.1128/IAI.03009-14 |
36812236 | Effects of anti-malarial prophylaxes on maternal transfer of Immunoglobulin-G(IgG) and association to immunity against Plasmodium falciparum infections amongchildren in a Ugandan birth cohort | Okek EJ, Ocan M, ..., Kamya MR | 10.1371/journal.pone.0277789 |
31234897 | Erythrocyte glycophorins as receptors for Plasmodium merozoites | Jaskiewicz E, Jodlowska M, Kaczmarek R, Zerka A | 10.1186/s13071-019-3575-8 |
23740926 | Acquired antibodies to merozoite antigens in children from Uganda withuncomplicated or severe Plasmodium falciparum malaria | Ahmed Ismail H, Ribacke U, ..., Persson KE | 10.1128/CVI.00156-13 |
23776178 | Erythrocyte-binding antigens of Plasmodium falciparum are targets of humaninhibitory antibodies and function to evade naturally acquired immunity | Persson KE, Fowkes FJ, ..., Beeson JG | 10.4049/jimmunol.1300444 |
21149582 | Reticulocyte and erythrocyte binding-like proteins function cooperatively ininvasion of human erythrocytes by malaria parasites | Lopaticki S, Maier AG, ..., Cowman AF | 10.1128/IAI.01021-10 |
24834503 | Patterns of selection on Plasmodium falciparum erythrocyte-binding antigens after the colonization of the New World | Yalcindag E, Rougeron V, ..., Prugnolle F | 10.1111/mec.12696 |
35637187 | Stochastic expression of invasion genes in Plasmodium falciparum schizonts | Tripathi J, Zhu L, ..., Bozdech Z | 10.1038/s41467-022-30605-z |
19204093 | Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in Plasmodium falciparum | Maier AG, Baum J, ..., Cowman AF | 10.1128/IAI.01331-08 |